Vaccination Geography and Access

The geography of vaccination coverage reflects a layered set of barriers — physical infrastructure, financing, political stability, and public trust — that together determine whether a vaccine developed and manufactured in one part of the world actually reaches a child or adult in another. The WHO's Expanded Programme on Immunization, launched in 1974, established the basic architecture of routine childhood immunization still used across most of the world today, and by the early 2020s the WHO and UNICEF's joint reporting system estimated that global coverage of the third dose of the diphtheria-tetanus-pertussis vaccine (DTP3), a standard benchmark indicator, had reached roughly 84 percent worldwide — but with sharp regional variation, dropping well below that figure across much of the Sahel region of Africa, Yemen, and parts of conflict-affected South Asia. The cold chain — the unbroken sequence of refrigerated storage and transport required to keep most vaccines viable from manufacture to administration — is a defining physical-geographic constraint on this coverage, since a single break in refrigeration, whether from unreliable electricity, poor road access, or extreme heat, can render a vaccine batch ineffective, making cold-chain logistics one of the most persistent technical challenges in reaching remote or infrastructure-poor regions.